FinCanna Capital’s 100% Owned ezGreen Announces Licensed Cannabis Events Schedule in City of Adelanto, California
VANCOUVER, BC / ACCESSWIRE / October 13, 2021 / FinCanna Capital Corp. (“FinCanna“) (CSE:CALI)(OTCQB:FNNZF), is pleased to announce its ezGreen proprietary software previously approved by the City of Adelanto, CA as an official Point of more...
Stevia Corp. Announces Non-Binding Purchase Offer for California-based Consumer Products Company
NEW YORK, NY / ACCESSWIRE / October 13, 2021 / Stevia Corp. (OTC PINK:STEV) (“Stevia Corp” or the “Company”), a healthcare company focused on the commercial development of products that support a healthy lifestyle announced more...
NOHO, INC. ANNOUNCES PRODUCT DEVELOPMENT DEAL WITH GAMING INFLUENCER D LUCKY
Scottsdale, Arizona, Oct. 13, 2021 (GLOBE NEWSWIRE) — NOHO, Inc. (OTC PINK: DRNK), a Wyoming corporation (the “Company”), announced the following: The Company is proud to announce a product development agreement with Las Vegas-based gaming influencer, more...
Abeona Therapeutics Announces Clinical Data Presentations at Upcoming Scientific Congresses
NEW YORK and CLEVELAND, Oct. 13, 2021 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced two presentations of previously disclosed clinical data at upcoming scientific more...
Clearside Biomedical Delivers Podium and Poster Presentations at the American Society of Retina Specialists (ASRS) Annual Meeting
Multiple clinical data presentations demonstrate the potential of the suprachoroidal injection platform as a flexible, in-office, non-surgical procedure across multiple chorioretinal diseases ALPHARETTA, Ga., Oct. 13, 2021 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical more...
Evelo Biosciences Presents Preclinical Data for EDP1867 at 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
–Data suggest SINTAX™ medicine may overcome blood-brain barrier limitations to anti-inflammatory drug delivery– –EDP1867 reduced disease severity and incidence of relapse in murine model of multiple sclerosis– –Data support development of EDP1867 for the treatment more...
Trevena Announces Two OLINVYK® Presentations at ANESTHESIOLOGY® 2021
Posters highlight safety and tolerability data in two complex patient populations at higher risk for adverse events CHESTERBROOK, Pa., Oct. 13, 2021 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN) , a biopharmaceutical company focused on more...
Sphere 3D and Gryphon Secure Largest Single Hosting Services Deal in Core Scientific’s History
228 MW hosting agreement is largest in Core Scientific’s history, with an estimated capacity of 71,000 miners Toronto, Ontario–(Newsfile Corp. – October 13, 2021) – Sphere 3D Corp. (NASDAQ: ANY) (“Sphere 3D” or the “Company”), more...
Anaconda Mining Reports Q3 Production Results and Announces Updated Mineral Reserve and Resource for Argyle
TORONTO, ON / ACCESSWIRE / October 13, 2021 / Anaconda Mining Inc. (“Anaconda” or the “Company”) (TSX:ANX)(OTCQX:ANXGF) is today announcing production results and certain financial information from the three and nine months ended September 30, more...
NanoViricides, Inc. Has Filed its Annual Report: Coronavirus Drug Program Rapidly Moving Towards Clinical Stage
SHELTON, CT / ACCESSWIRE / October 13, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that it has filed its Annual Report on Form 10-K for the fiscal year ending June 30, 2021 with more...